MENORA MIVTACHIM HOLDINGS LTD.MENORA MIVTACHIM HOLDINGS LTD.

Institutional investor · Portfolio as of Q3 2023

SEC EDGAR SourceSEC Filings

Top Holdings95 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction

MICROSOFT CORP

2.9M$909.4M8.3%$221.46+40.19%
19 qtrssince 2019-Q1
Increased
63

APPLE INC

4.1M$700.5M6.4%$124.54+35.64%
19 qtrssince 2019-Q1
Increased
61

ALPHABET INC-CL A

4.9M$637.1M5.8%$98.35+32.06%
19 qtrssince 2019-Q1
Increased
61

APPLIED MATERIALS INC

3.1M$425.3M3.9%$119.54+13.25%
11 qtrssince 2021-Q1
Decreased
0

MASTERCARD INC - A

1M$398.2M3.6%$338.46+15.30%
11 qtrssince 2021-Q1
Increased
57

META PLATFORMS INC-CLASS A

1.1M$338M3.1%$258.32+15.41%
14 qtrssince 2020-Q2
Increased
57
XLVXLV
ETF

HEALTH CARE SELECT SECTOR SPDR

2.5M$328.2M3.0%$122.35+1.33%
3 qtrssince 2023-Q1
Decreased
0

AMAZON.COM INC

2.4M$306.4M2.8%$110.49+15.05%
19 qtrssince 2019-Q1
Increased
53
TEVATEVA
ADR

TEVA PHARMACEUTICAL-SP ADR

28.1M$286.9M2.6%$9.33+9.31%
16 qtrssince 2019-Q4
Increased
56

UNITEDHEALTH GROUP INC

563,961$284.3M2.6%$468.28+3.11%
4 qtrssince 2022-Q4
Increased
67

WALMART INC

1.6M$258.3M2.3%$41.57+25.06%
19 qtrssince 2019-Q1
Increased
58
EMXCEMXC
ETF

ISHARES MSCI EMR MRK EX CHNA

5M$250.8M2.3%$46.31+0.54%
3 qtrssince 2023-Q1
Increased
59
FLKRFLKR
ETF

FRANKLIN TEMPLETON ETF TR

12.2M$247.9M2.3%$18.50-1.89%
3 qtrssince 2023-Q1
Increased
58
XLFXLF
ETF

FINANCIAL SELECT SECTOR SPDR

7.3M$243.4M2.2%$30.45+5.25%
3 qtrssince 2023-Q1
Decreased
0

ABBOTT LABORATORIES

2.4M$230.8M2.1%$97.46-6.64%
13 qtrssince 2020-Q3
Increased
66

CF INDUSTRIES HOLDINGS INC

2.5M$217.5M2.0%$72.93+10.77%
2 qtrssince 2023-Q2
Increased
76

THERMO FISHER SCIENTIFIC INC

423,889$214.6M1.9%$391.33+28.45%
19 qtrssince 2019-Q1
Increased
48
FLINFLIN
ETF

FRANKLIN TEMPLETON ETF TR

6.3M$200.8M1.8%$30.17+1.99%
2 qtrssince 2023-Q2
Increased
69

TESLA INC

797,485$199.5M1.8%$257.22-2.72%
2 qtrssince 2023-Q2
Increased
50

EQT CORP

4.7M$190M1.7%$35.34+10.07%
3 qtrssince 2023-Q1
Increased
56
$11B
AUM
95
Positions
Q3 2023
Filing
Rating · 2.0
Quarterly Portfolio Change
-21%Q2'22$5.5B-3%Q3'22$5.3B+12%Q4'22$5.9B+63%Q1'23$9.7B+12%Q2'23$10.8B+2%Q3'23$11B
Activity profile
$ moved · Q3'23
New18%Increased44%Decreased23%Exited14%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 2.0 years
<1Q9%1-4Q39%1-2Y5%2Y+46%

MENORA MIVTACHIM HOLDINGS LTD. manages $11B across 95 positions as of Q3 2023. Top holdings: MSFT (8.3%), AAPL (6.4%), GOOGL (5.8%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 2/5.0.

Q3 2023 Summary

Active quarter - 10 new positions, 10 exits, 36 increased. Top move: CF (INCREASED, conviction 76). Portfolio: $11.0B across 95 positions.

Top holdings by portfolio weight

Total AUM$11B
MSFT8.25%
AAPL6.36%
GOOGL5.78%
AMAT3.86%
MA3.61%
META3.07%
XLV2.98%
AMZN2.78%
TEVA2.60%
UNH2.58%
Other2.34%

Portfolio allocation by GICS sector

Sectors11
Technology28.84%
Unknown18.37%
Healthcare11.07%
Communication Services9.39%
Consumer Cyclical7.78%
Financial Services7.73%
Industrials4.22%
Consumer Defensive3.85%
Basic Materials3.34%
Energy2.78%
Other2.62%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Technology, Unknown, Healthcare
Compare DNA across all funds
7-dimension quality assessment
Below Average(2.0 / 5.0)
Track Record52
Conviction45
Concentration62
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
6Q
TEVATEVATEVA PHARMACEUTICAL-SP ADR
Q1 2025 Q2 2026+11.5M shares+$724.7M
5Q
KREKRESPDR SERIES TRUST
Q2 2025 Q2 2026+3.3M shares+$248M
4Q
QQQQQQINVESCO QQQ TRUST SERIES 1 CL USD INC
Q3 2025 Q2 2026+10,060 shares+$9.7M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used